Business Context and Reporting Period
Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended December 31, 1997 (Fiscal Year 1998).
Business Overview: The Company operates in the multi-level distribution industry, manufacturing and distributing health and wellness products. Operations include wholly-owned subsidiaries such as Millennium Health International, Inc. and CellLife International, Inc.
Key Financial Metrics
| Metric | Six Months Ended Dec 31, 1997 | Six Months Ended Dec 31, 1996 | Quarter Ended Dec 31, 1997 | Quarter Ended Dec 31, 1996 |
|---|---|---|---|---|
| Net Sales | $28,329,917 | $24,067,255 | $16,297,341 | $12,630,234 |
| Gross Profit | $7,603,915 | $6,476,594 | $4,442,561 | $3,215,954 |
| Gross Margin | 26.8% | 26.9% | 27.3% | 25.5% |
| Net Earnings | $1,961,443 | $1,749,665 | $1,363,023 | $849,292 |
| Diluted EPS | $0.35 | $0.31 | $0.24 | $0.15 |
| Cash & Equivalents (End Period) | $3,285,292 (Dec 31, 1997) | |||
| Working Capital | $12,499,000 (Dec 31, 1997) | |||
| Total Debt (Current + Long-term) | $1,071,537 (Dec 31, 1997) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 18% for the six months and 29% for the quarter compared to the prior year. Growth was driven by sales to new customers and a significant expansion in international sales (from $0.8M to $8.0M for the six-month period).
- Profitability: Net earnings rose 12% for the six months and 60% for the quarter. The quarterly increase was driven by improved gross margins (27.3% vs 25.5%) due to manufacturing efficiencies.
- Expense Trends: Selling, general, and administrative (SG&A) expenses increased in absolute dollars due to the adoption of a new defined benefit pension plan on January 1, 1997, and depreciation from a new tablet manufacturing facility. However, SG&A as a percentage of sales decreased for the quarter (13.4% vs 14.4%).
- Balance Sheet: Inventories increased significantly from $5.7M to $8.2M to fulfill an increased sales order backlog. Cash and cash equivalents decreased slightly by $184,447 during the six-month period.
Guidance, Outlook, and Risks
- Liquidity: Management believes internally generated cash flow, combined with existing credit facilities, is sufficient to fund operations and capital expenditures. The Company has a $3,000,000 revolving line of credit (secured by receivables, inventory, and equipment) with no borrowings outstanding as of December 31, 1997.
- Capital Expenditures: The Company has purchase commitments of approximately $650,000 for additional production equipment expected to be placed in service in the third quarter.
- Customer Concentration Risk: Four customers accounted for 68% of total sales for the six months ended December 31, 1997. The loss of any of these customers could have an adverse impact on revenues.
- Legal Proceedings: The Company is involved in various ordinary course legal actions, which management does not expect to have a material adverse impact.
Investor Verification Checklist
- Inventory Build-up: Verify the necessity of the $2.5M increase in inventory against actual sales order backlogs to ensure no obsolescence risk.
- Customer Concentration: Assess the stability of the top four customers who represent 68% of revenue.
- Pension Plan Impact: Monitor the cash flow impact of the new defined benefit pension plan adopted in January 1997.
- International Expansion: Confirm the sustainability of the rapid growth in international sales (increased from $0.5M to $4.3M in one quarter).
- Debt Covenants: Review the terms of the $3M revolving credit line and any potential covenants related to the new manufacturing facility.